FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088009624> ?p ?o ?g. }

• W3088009624 endingPage "1275" @default.
• W3088009624 startingPage "1267" @default.
• W3088009624 abstract "Osteoporosis medication use is suboptimal. Simple interventions personalized to a patients' stage of readiness are needed to encourage osteoporosis medication use.To estimate interrelationships of sociodemographic factors, perceived fracture risk, health literacy, receipt of medication information, medication trust and readiness to use osteoporosis medication; and apply observed relationships to inform design specifications for a clinical decision support application that can be used for personalized patient counseling.Data from a national sample of older women (n = 1759) with self-reported history of fractures and no current use of osteoporosis medication treatment were used to estimate an acceptable path model that describes associations among key sociodemographic characteristics, health literacy, perceived fracture risk, receipt of osteoporosis medication information within the past year, trust in osteoporosis medications, and readiness to use osteoporosis medication. Path model results were used to inform an application for personalized patient counseling that can be easily integrated into clinical decision support systems.Increased age (β = 0.13), trust for medications (β = 0.12), higher perceived fracture risk (β = 0.21), and having received medication information within the past year (β = 0.21) were all positively associated with readiness to use osteoporosis medication (p < 0.0001). Whereas, health literacy (β = -0.09) was inversely associated with readiness to use osteoporosis medication (p < 0.0001). Using these results, a brief 6-item question set was constructed for simple integration into clinical decision support applications. Patient responses were used to inform a provider dashboard that integrates a patient's stage of readiness for osteoporosis medication use, predictors of readiness, and personalized counseling points appropriate to their stage of readiness.Content of counseling strategies must be aligned with a patient's stage of readiness to use treatment. Path modeling can be effectively used to identify factors for inclusion in an evidenced-based clinical decision support application designed to assist providers with personalized patient counseling and osteoporosis medication use decisions." @default.
• W3088009624 created "2020-10-01" @default.
• W3088009624 creator A5041229626 @default.
• W3088009624 creator A5046382845 @default.
• W3088009624 creator A5071641808 @default.
• W3088009624 creator A5077485876 @default.
• W3088009624 creator A5078114203 @default.
• W3088009624 creator A5084524552 @default.
• W3088009624 creator A5090565512 @default.
• W3088009624 date "2021-07-01" @default.
• W3088009624 modified "2023-10-16" @default.
• W3088009624 title "Use of path modeling to inform a clinical decision support application to encourage osteoporosis medication use" @default.
• W3088009624 cites W1606867770 @default.
• W3088009624 cites W1741567663 @default.
• W3088009624 cites W1908729563 @default.
• W3088009624 cites W1929301364 @default.
• W3088009624 cites W1965170822 @default.
• W3088009624 cites W1965598713 @default.
• W3088009624 cites W1967533376 @default.
• W3088009624 cites W1969133253 @default.
• W3088009624 cites W1972735706 @default.
• W3088009624 cites W1976359559 @default.
• W3088009624 cites W1977176593 @default.
• W3088009624 cites W1990621873 @default.
• W3088009624 cites W1993035292 @default.
• W3088009624 cites W1996292235 @default.
• W3088009624 cites W2005298224 @default.
• W3088009624 cites W2013724724 @default.
• W3088009624 cites W2021604300 @default.
• W3088009624 cites W2049431401 @default.
• W3088009624 cites W2060729761 @default.
• W3088009624 cites W2061672958 @default.
• W3088009624 cites W2070098862 @default.
• W3088009624 cites W2088518643 @default.
• W3088009624 cites W2088688002 @default.
• W3088009624 cites W2089872166 @default.
• W3088009624 cites W2096329415 @default.
• W3088009624 cites W2098086978 @default.
• W3088009624 cites W2101183898 @default.
• W3088009624 cites W2109223853 @default.
• W3088009624 cites W2124527463 @default.
• W3088009624 cites W2126800506 @default.
• W3088009624 cites W2147139800 @default.
• W3088009624 cites W2149098146 @default.
• W3088009624 cites W2169978819 @default.
• W3088009624 cites W2171709369 @default.
• W3088009624 cites W2319932633 @default.
• W3088009624 cites W2460799613 @default.
• W3088009624 cites W2461516439 @default.
• W3088009624 cites W2475734208 @default.
• W3088009624 cites W2482709168 @default.
• W3088009624 cites W2561956914 @default.
• W3088009624 cites W2614075773 @default.
• W3088009624 cites W2765708645 @default.
• W3088009624 cites W2789722783 @default.
• W3088009624 cites W2799391326 @default.
• W3088009624 cites W2966517548 @default.
• W3088009624 cites W3005040570 @default.
• W3088009624 doi "https://doi.org/10.1016/j.sapharm.2020.09.010" @default.
• W3088009624 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33011082" @default.
• W3088009624 hasPublicationYear "2021" @default.
• W3088009624 type Work @default.
• W3088009624 sameAs 3088009624 @default.
• W3088009624 citedByCount "0" @default.
• W3088009624 crossrefType "journal-article" @default.
• W3088009624 hasAuthorship W3088009624A5041229626 @default.
• W3088009624 hasAuthorship W3088009624A5046382845 @default.
• W3088009624 hasAuthorship W3088009624A5071641808 @default.
• W3088009624 hasAuthorship W3088009624A5077485876 @default.
• W3088009624 hasAuthorship W3088009624A5078114203 @default.
• W3088009624 hasAuthorship W3088009624A5084524552 @default.
• W3088009624 hasAuthorship W3088009624A5090565512 @default.
• W3088009624 hasBestOaLocation W30880096242 @default.
• W3088009624 hasConcept C107327155 @default.
• W3088009624 hasConcept C134018914 @default.
• W3088009624 hasConcept C136764020 @default.
• W3088009624 hasConcept C154945302 @default.
• W3088009624 hasConcept C159110408 @default.
• W3088009624 hasConcept C160735492 @default.
• W3088009624 hasConcept C162324750 @default.
• W3088009624 hasConcept C1862650 @default.
• W3088009624 hasConcept C27415008 @default.
• W3088009624 hasConcept C2776541429 @default.
• W3088009624 hasConcept C2777929519 @default.
• W3088009624 hasConcept C2778843546 @default.
• W3088009624 hasConcept C2778979077 @default.
• W3088009624 hasConcept C41008148 @default.
• W3088009624 hasConcept C50522688 @default.
• W3088009624 hasConcept C512399662 @default.
• W3088009624 hasConcept C63527458 @default.
• W3088009624 hasConcept C71924100 @default.
• W3088009624 hasConceptScore W3088009624C107327155 @default.
• W3088009624 hasConceptScore W3088009624C134018914 @default.
• W3088009624 hasConceptScore W3088009624C136764020 @default.
• W3088009624 hasConceptScore W3088009624C154945302 @default.
• W3088009624 hasConceptScore W3088009624C159110408 @default.
• W3088009624 hasConceptScore W3088009624C160735492 @default.
• W3088009624 hasConceptScore W3088009624C162324750 @default.

• next